No internet connection — showing the saved version of the page.

Revolution Medici…

USUSD
← to the screener

Revolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Number of exchanges where the company shares trade: 1. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
revmed.com
Investor relations
revmed.com/investors/
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Headquarters
REDWOOD CITY, United States
CEO
Dr. Mark A. Goldsmith M.D., Ph.D.
Employees
883
Founded
2014
Shares outstanding
214.34 M as of 2026-07-31
Free float
184.5 M
Market cap
43.24 B USD
Insiders
1.85%
Institutions
101.01%
Industry (SIC)
Biological Products, (No Diagnostic Substances)
ISIN
US76155X1000
LEI
549300JU3X0LBCQ65892
Description

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksRVMDUSD200.87 +0.50%common stock

Price for 3 months

US:RVMD · USD
up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

No dividend payments found (checked 08.10.2026). The company probably does not pay dividends.

News this week

No news from the company's website yet.

advertisement

Top holders

HolderStakeSharesReport date
Blackrock Inc.6.39%13.7 M2026-06-30
Farallon Capital Managem…6.32%13.55 M2026-06-30
FMR, LLC5.69%12.2 M2026-06-30
Baker Bros. Advisors, LP5.34%11.44 M2026-06-30
Jupiter Topco LLC5.01%10.74 M2026-06-30
Darwin Global Management…4.96%10.63 M2026-06-30
Vanguard Capital Managem…4.24%9.09 M2026-06-30
Vanguard Portfolio Manag…3.87%8.29 M2026-06-30
Nextech Invest, Ltd.3.55%7.6 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.99%6.41 M2026-06-30
Paradigm Biocapital Advi…2.97%6.36 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.16%4.63 M2026-06-30
Growth Fund of America1.38%2.96 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.25%2.67 M2026-06-30
Fidelity Mt. Vernon Stre…1.15%2.47 M2026-07-31
BORISY ALEXIS (Director)≈1.09%2.34 M2026-06-18
VANGUARD INDEX FUNDS-Van…1.07%2.29 M2026-06-30
VANGUARD SPECIALIZED FUN…0.86%1.84 M2026-04-30
iShares Trust-iShares Bi…0.65%1.39 M2026-07-31
JPMorgan Trust II-JPMorg…0.54%1.17 M2026-06-30
iShares Trust-iShares Ru…0.51%1.1 M2026-07-31
GOLDSMITH MARK A (Chief…≈0.46%984 2382026-08-21
KELSEY STEPHEN MICHAEL (…≈0.14%291 8762026-09-11
HORN MARGARET A (Chief O…≈0.07%154 6472026-06-17
ANDERS JACK LEE (Chief F…≈0.06%123 2692026-06-24
WANG XIAOLIN (Officer)≈0.05%116 0632026-03-17
LIN WEI (Officer)≈0.05%101 3662026-03-17
HORNING SANDRA (Director…≈0.05%97 7652026-06-18
CISLINI JEFFREY TODD (Ge…≈0.03%55 9072026-08-21
SCHROEDER THILO (Directo…——2024-12-05